Cargando…
Antibody-dependent passive protection of mucosal surfaces
Extensive experiments performed mostly in a variety of animal models convincingly demonstrated the protective effect of polyclonal or monoclonal antibodies administered by the mucosal route. Because of the independence of the mucosal and systemic compartments of the immune system, antibodies from th...
Autor principal: | Mestecky, Jiri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103488/ https://www.ncbi.nlm.nih.gov/pubmed/33939589 http://dx.doi.org/10.1080/21645515.2021.1899549 |
Ejemplares similares
-
Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases
por: Tharmalingam, Tharmala, et al.
Publicado: (2021) -
Inhaled antibodies: Quality and performance considerations
por: Hickey, Anthony James, et al.
Publicado: (2021) -
The biophysical principles underpinning muco-trapping functions of antibodies
por: Schaefer, Alison, et al.
Publicado: (2021) -
Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing
por: Whaley, Kevin J, et al.
Publicado: (2021) -
The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
por: Richards, Angelene, et al.
Publicado: (2021)